From: Biological effects of the oxygen molecule in critically ill patients
✓ Oxygenation | |
 • Increase in arterial oxygen content and hence systemic oxygen delivery | |
 • Variable efficacy depending on the type of hypoxia | |
✓ Circulation | |
 • Systemic vasoconstriction | |
  • Increase in systemic vascular resistance and hence systemic arterial pressure | |
  • Decrease in cardiac stroke volume and cardiac output | |
  • Possible decrease in tissue blood flow | |
 • Pulmonary vasodilation in affected area by inhaled oxygen | |
  • Decrease in pulmonary vascular resistance and hence pulmonary arterial pressure | |
  • Increase in pulmonary blood flow | |
  • Decrease in right-to-left intracardiac shunt flow, if it exists | |
 • Regional perfusion | |
  • Decrease in coronary blood flow | |
  • Aggravation of ischemic damage in myocardial infarction | |
✓ Cellular toxicity | |
 • Inflammation: Induction of pro-inflammatory cytokines | |
 • Production of reactive oxygen species | |
  • Enhanced neurological damage after ischemia reperfusion | |
  • Induced lung injury and possible dysfunction of other organs | |
✓ Others | |
 • Occurrence of resorption atelectasis | |
 • Impairment of mucociliary clearance in trachea/bronchus | |
 • Compromised innate immunity |